The impact of travel distance, travel time and waiting time on health-related quality of life of diabetes patients: An investigation in six European countries

- Health-related quality of life of TD2 patients decreases with travel time to the care provider.
- Health-related quality of life of TD2 patients decreases with waiting time in the provider practice.
- After control for travel time travel distance has no impact on health-related quality of life of TD2 patients.

AimsThe effects of travel distance and travel time to the primary diabetes care provider and waiting time in the practice on health-related quality of life (HRQoL) of patients with type 2 diabetes are investigated.Research design and methodsSurvey data of 1313 persons with type 2 diabetes from six regions in England (274), Finland (163), Germany (254), Greece (165), the Netherlands (354), and Spain (103) were analyzed. Various multiple linear regression analyses with four different EQ-5D-3L indices (English, German, Dutch and Spanish index) as target variables, with travel distance, travel time, and waiting time in the practice as focal predictors and with control for study region, patient's gender, patient's age, patient's education, time since diagnosis, thoroughness of provider-patient communication were computed. Interactions of regions with the remaining five control variables and the three focal predictors were also tested.ResultsThere are no interactions of regions with control variables or focal predictors. The indices decrease with increasing travel time to the provider and increasing waiting time in the provider's practice.ConclusionsHRQoL of patients with type 2 diabetes might be improved by decreasing travel time to the provider and waiting time in the provider's practice.